Skip to content

The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital

The Status of Helicobacter Pylori Infection Among Children Visiting Assiut Children Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04212585
Enrollment
100
Registered
2019-12-27
Start date
2021-01-01
Completion date
2022-01-01
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori Infection

Brief summary

The aim of this study is to estimate the prevalence of Helicobacter pylori infection among Egyptian children attending to healthcare facilitates using different diagnostic tools.

Detailed description

The prevalence of H. pylori infection, which has a ubiquitous distribution, varies depending on socioeco- nomic factors and age. in the context of a decreased trend in H. pylori prevalence, at least 50% of the world's hu-man population are carriers of the microorganism, with a prevalence much higher in developing countries than in developed countries. H. pylori infection was evaluated in 286 Egyptian school children, and the overall prevalence was \> 72%. Acquisition of the infection occurs mostly in early childhood; therefore, a better understanding of the epidemiology and the risk factors associated with H. pylori infection in the pediatric population is important to clarify the natural history and complications of the infection and programming eradication strategies. Currently, little data exist regarding the epidemiology of H. pylori associated infection in our region., especially in children. Therefore, this study aims to determine the prevalence of H. pylori among children.

Interventions

DIAGNOSTIC_TESTSerology test

Serology for Helicobacter pylori (immunoglobulin G for all sites, immunoglobulin M optional, immunoglobulin A optional) will be collected from all participants. 90 samples (immunoglobulin G, immunoglobulin M and immunoglobulin A) at least needed from each site. Stool antigen for Helicobacter pylori

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* All children (\<18 years) attending healthcare facilities for any reason will be enrolled after informed consent of their parents to participate in the study. Participants will be recruited from the following sources: 1. Children with non-GI symptoms (ophthalmology, ear, nose, and throat , chest departments .. etc) 2. Children with GI symptoms undergoing upper GI endoscopy (from GI endoscopy units). Simple questionnaire will be used to collect demographic data, socioeconomic status, dietary habits, and gastrointestinal complaints from parents of all participants before testing for Helicobacter pylori.

Exclusion criteria

1. Patients refusing to be enrolled in the study. 2. For any diagnostic test other than serology (stool antigen, rapid Urease test, urea breath test, histopathology) the following patients will be excluded: * Children received any antibiotics in the last month * Children received bismuth compounds in the last month. * Children received proton pump inhibitors in the last 2 weeks. * Children presenting with upper gastrointestinal bleeding.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of H. pylori in children hospital attendees.2 yearsWe need to estimate prevalence of H.Pylori infection among all children admitted in Assiut University Hospital.

Contacts

Primary ContactEbtihal R Hashem, MB
ebtihalrhs2015@gmail.com+201060633506
Backup ContactMohammed A Medhat Nasr, M.D.
mmedhat83@gmail.com+201099922736

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026